etoposide has been researched along with Deep Vein Thrombosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Aziri, R; Chovanec, M; Hulova, S; Kolnikova, G; Mardiak, J; Mego, M; Palacka, P; Pindak, D; Rejlekova, K; Vulev, I | 1 |
| Géczi, L; Küronya, Z; Németh, H | 1 |
| Chen, W; Jun, HZ; Kang, JR; Long, LH; Wei, WW; Yan, SW | 1 |
| Ariyoshi, N; Kitada, M; Koga, H; Nakamura, H; Nakasa, H; Nakaseko, C; Nishimura, M; Saeki, H; Suzuki, T; Tanaka, H; Yamazaki, S | 1 |
| Claxton, D; Fink, LM; Ibrahim, S; Talamo, GP; Tricot, GJ; Zangari, M | 1 |
| Agarwala, S; Bisoi, AK; Das, S; Gupta, AK; Malankar, DP; Munghate, G; Sugandhi, N | 1 |
| Barlogie, B; Eddleman, P; Fassas, A; Fink, L; Jacobson, J; Lee, CK; Talamo, G; Thertulien, R; Tricot, G; Van Rhee, F; Zangari, M | 1 |
| Ardito, R; Cammarota, A; Di Renzo, N; Gallucci, G; Romano, G; Tartarone, A | 1 |
| Patel, A; Rane, A; Wilson, L | 1 |
| Di Leo, A; Guimarães, JL; Mano, MS; Reiriz, AB; Sutmöller, CS; Sutmöller, SF | 1 |
| Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T | 1 |
| Cheng, WS; Choy, DK; Tan, BS; Yip, SK | 1 |
| Crawford, ED; Dakhil, SR; Eisenberger, MA; Fisher, EI; Goodwin, JW; Hussain, MH; Jones, JA; Mills, GM; Pienta, KJ | 1 |
| Gutierrez, M; Horne, M; Jaffe, ES; Little, RF; Pau, A; Wilson, W | 1 |
| Anaissie, E; Badros, A; Barlogie, B; Desikan, R; Fink, L; Gopal, AV; Morris, C; Siegel, E; Toor, A; Tricot, G; Zangari, M | 1 |
| Anaissie, E; Badros, A; Barlogie, B; Desikan, R; Fassas, A; Fink, L; Mehta, P; Morris, C; Saghafifar, F; Siegel, E; Toor, A; Tricot, G; Whitfield, D; Zangari, M | 1 |
4 trial(s) available for etoposide and Deep Vein Thrombosis
| Article | Year |
|---|---|
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Portal Vein; Prospective Studies; Severity of Illness Index; Tablets, Enteric-Coated; Tegafur; Time Factors; Treatment Outcome; Uracil; Venous Thrombosis | 2007 |
A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgens; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Estramustine; Etoposide; Humans; Male; Middle Aged; Nausea; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome; Venous Thrombosis | 2001 |
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.
Topics: Adult; Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Factors; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Multiple Myeloma; Risk; Risk Factors; Thalidomide; Venous Thrombosis; Vincristine | 2001 |
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.
Topics: Activated Protein C Resistance; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Factor V; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Life Tables; Male; Middle Aged; Multiple Myeloma; Risk; Thalidomide; Thrombophilia; Venous Thrombosis; Vincristine | 2002 |
12 other study(ies) available for etoposide and Deep Vein Thrombosis
| Article | Year |
|---|---|
Successful emergency endovascular aortic repair for intratumoral hemorrhage in extensive retroperitoneal mass of testicular origin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Aortic Rupture; Bleomycin; Cisplatin; Computed Tomography Angiography; Endovascular Procedures; Etoposide; Hemorrhage; Humans; Iliac Vein; Lymph Node Excision; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Retroperitoneal Neoplasms; Testicular Neoplasms; Vascular Neoplasms; Vena Cava, Inferior; Venous Thrombosis | 2020 |
[Successful treatment of metastatic testicular tumor of extreme size].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Depression; Disease Progression; Drug Administration Schedule; Etoposide; Febrile Neutropenia; Humans; Interdisciplinary Communication; Male; Middle Aged; Orchiectomy; Patient Care Team; Prognosis; Quality of Life; Remission Induction; Status Epilepticus; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis | 2014 |
Peripherally Inserted Central Catheter-Related Vein Thrombosis in Patients With Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Catheterization, Central Venous; Cohort Studies; Etoposide; Female; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Risk Factors; Venous Thrombosis | 2017 |
Probable interaction between warfarin and antitumor agents used in R-ESHAP chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Interactions; Etoposide; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Pulmonary Embolism; Venous Thrombosis; Warfarin | 2008 |
Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
Topics: Activated Protein C Resistance; Angiogenesis Inhibitors; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Doxorubicin; Etoposide; Factor V; Follow-Up Studies; Humans; Hyperhomocysteinemia; Multiple Myeloma; Prednisone; Pulmonary Embolism; Retrospective Studies; Thalidomide; Thrombophilia; Venous Thrombosis | 2009 |
Pediatric clear cell sarcoma of the kidney with cavoatrial thrombus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiopulmonary Bypass; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Heart Atria; Hepatic Veins; Humans; Kidney Neoplasms; Male; Neoadjuvant Therapy; Nephrectomy; Sarcoma, Clear Cell; Thrombectomy; Tomography, X-Ray Computed; Ultrasonography; Vena Cava, Inferior; Venous Thrombosis; Vincristine; Wilms Tumor | 2011 |
Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Humans; Multiple Myeloma; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Venous Thrombosis; Vincristine | 2003 |
Venous thromboembolism after high-dose chemotherapy in a patient with Hodgkin's lymphoma receiving the new oral contraceptive ethinylestradiol and drospirenone ("Yasmine").
Topics: Adult; Androstenes; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Contraceptives, Oral, Synthetic; Cytarabine; Etoposide; Female; Hodgkin Disease; Humans; Immunotherapy; International Normalized Ratio; Lynestrenol; Melphalan; Mineralocorticoid Receptor Antagonists; Risk; Risk Factors; Time Factors; Venous Thrombosis; Warfarin | 2005 |
Primary retroperitoneal seminoma presenting with inferior vena caval obstruction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Etoposide; Humans; Male; Middle Aged; Retroperitoneal Neoplasms; Seminoma; Treatment Outcome; Ultrasonography; Vascular Diseases; Vena Cava, Inferior; Venous Thrombosis | 2005 |
Extensive deep vein thrombosis as a complication of testicular cancer treated with the BEP protocol (bleomycin, etoposide and cisplatin): case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Fibrinolytic Agents; Humans; Male; Streptokinase; Testicular Neoplasms; Ultrasonography, Doppler, Duplex; Vena Cava, Inferior; Venous Thrombosis | 2006 |
Clinics in diagnostic imaging (44). Testicular tumour with retroperitoneal lymphadenopathy and inferior vena cava thrombosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Etoposide; Humans; Lymphatic Diseases; Male; Pain; Radiography; Retroperitoneal Space; Testicular Neoplasms; Ultrasonography; Vena Cava, Inferior; Venous Thrombosis | 1999 |
HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biopsy, Needle; Cyclophosphamide; Doxorubicin; Etoposide; Flow Cytometry; HIV Infections; Humans; Immunohistochemistry; Immunophenotyping; Incidence; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Thrombolytic Therapy; Venous Thrombosis; Vincristine | 2001 |